GT Biopharma, Inc. Announces 1-for-30 Reverse Stock SplitGlobe Newswire • 3 months agoBRISBANE, CALIFORNIA, Feb. 01, 2024 (GLOBE NEWSWIRE) -- GT Biopharma, Inc. (NASDAQ: GTBP) (the Company ), a clinical stage immuno-oncology company focused on developing innovative therapeutics...